Skip to content

Effect of rhPTH on bone metabolism of Postmenopausal Osteoporosis: a randomized control trial

Effect of rhPTH on bone metabolism of Postmenopausal Osteoporosis: a randomized control trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001313
Enrollment
Unknown
Registered
2011-04-29
Start date
2009-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopausal Osteoporosis

Interventions

Goup A:rhPTH
Group B:elcatonin

Sponsors

Gangyi Yang
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Postmenopausal wemon of 50 to 75 years old 2. Criteria of osteoporosis in 1994, including one of the following: 1) BMD of lumbar vertebrae =<2.5SD (DEXA method); 2) compression fracture in one of the lumbar vertebrae and T<1.0SD.

Exclusion criteria

Exclusion criteria: 1. Non-primary osteoporosis or bone diseases caused by renal failure, Osteomalacia, etc. 2. Uncontroled diabetes with HbA1c>7% or with other serious complication, other endocrine disease such as hyperthyoidism; 3. Impaired hepatic function with ALT higher than 2 X upper limit of normal; 4. Impaired renal function with serum Cr higher than upper limit of normal;Myocardial infarction, stroke 5. Use other anti osteoporosis drugs within 6 months prior to informed consent.

Design outcomes

Primary

MeasureTime frame
BMD;factors correlated bone metabolism;

Countries

China

Contacts

Public ContactGangyi Yang
gangyiyang@yahoo.com.cn+86 023 68485216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026